Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000253

Director sold 667 shares at $80.86 ($53,934)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Malady Kyle Director 2025-09-05 Sale 10b5-1 −667 $80.86 $53,934 22,667 D
Open-market sales · 667 sh · avg $80.86 · $53,934
Loading xslF345X05/wk-form4_1757449097.xml…